Skip to main content
Back to Mitsubishi UFJ Capital

Mitsubishi UFJ Capital's Life Science Portfolio

Browse 10 Life Science companies funded by Mitsubishi UFJ Capital. See funding amounts, founder contacts, and investment details.

Life Science Companies
10
Total Funding in Life Science
$139.7M

Life Science Portfolio Companies (10)

Export
BiopharmaBiotechnologyClinical TrialsLife ScienceMedicalTherapeutics

RegCell develops cell therapies designed to restore immune tolerance in autoimmune diseases.

Emeryville, United States
September 2026
$44.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsLife Science

Fermelanta is a biotech firm that produces rare plant-based ingredients through microbial fermentation.

Ishikawa, Japan
August 2025
$13.6M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalPharmaceutical

FELIQS is a research-based start-up specializing in pharmaceutical sciences.

Kurume, Japan
July 2025
$8.3M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife Science

Modalis is a biotech company that develops therapeutics using CRISPR based technology.

Tokyo, Japan
June 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareHealth DiagnosticsLife ScienceMedicalTherapeutics

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Wadenswil, Switzerland
January 2025
$54.9M
Series C

Founder Contacts

41,000+ verified contacts

AgricultureBiotechnologyEnvironmental ConsultingLife Science

GRA&GREEN is a biotechnology company that provides seed development for agriculture, forestry, and raw materials for food processing.

Nagoya, Japan
June 2024
$4.1M
Series C

Founder Contacts

41,000+ verified contacts

FitnessHealth CareLife Science

AuB is an intestinal microflora analysis that contributes to the athlete's performance improvement and human health maintenance.

Ginza, Japan
May 2024
$4.9M
Series C

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyGeneticsHealth CareLife Science

AceRNA Technologies is a biotech startup that develops patient-centric genetic therapies with RNA switch technology for drug discovery.

Kyoto, Japan
May 2024
$6.2M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyLife SciencePharmaceuticalProduct Design

StapleBio is a bio-tech company that focuses on the research and development of pharmaceuticals based on staple nucleic acid technology.

Kumamoto, Japan
April 2024
$3.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)Consumer ResearchLife Science

Memory Lab is a research laboratory that offers AI paper analysis and development solutions.

Tokyo, Japan
January 2024
$610K
Seed

Founder Contacts

41,000+ verified contacts

Explore Mitsubishi UFJ Capital's Full Portfolio

View all companies funded by Mitsubishi UFJ Capital across every industry and funding stage.

View Full Mitsubishi UFJ Capital Portfolio